These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Interactions among mu- and delta-opioid receptors, especially putative delta1- and delta2-opioid receptors, promote dopamine release in the nucleus accumbens. Hirose N, Murakawa K, Takada K, Oi Y, Suzuki T, Nagase H, Cools AR, Koshikawa N. Neuroscience; 2005; 135(1):213-25. PubMed ID: 16111831 [Abstract] [Full Text] [Related]
3. Absence of conditioned place preference or reinstatement with bivalent ligands containing mu-opioid receptor agonist and delta-opioid receptor antagonist pharmacophores. Lenard NR, Daniels DJ, Portoghese PS, Roerig SC. Eur J Pharmacol; 2007 Jul 02; 566(1-3):75-82. PubMed ID: 17383633 [Abstract] [Full Text] [Related]
9. Buprenorphine antinociception is abolished, but naloxone-sensitive reward is retained, in mu-opioid receptor knockout mice. Ide S, Minami M, Satoh M, Uhl GR, Sora I, Ikeda K. Neuropsychopharmacology; 2004 Sep 02; 29(9):1656-63. PubMed ID: 15100703 [Abstract] [Full Text] [Related]
12. Differential effects of delta- and mu-opioid receptor antagonists on the amphetamine-induced increase in extracellular dopamine in striatum and nucleus accumbens. Schad CA, Justice JB, Holtzman SG. J Neurochem; 1996 Dec 02; 67(6):2292-9. PubMed ID: 8931460 [Abstract] [Full Text] [Related]
19. Pentazocine-induced antinociception is mediated mainly by μ-opioid receptors and compromised by κ-opioid receptors in mice. Shu H, Hayashida M, Arita H, Huang W, Zhang H, An K, Wu G, Hanaoka K. J Pharmacol Exp Ther; 2011 Aug 17; 338(2):579-87. PubMed ID: 21543510 [Abstract] [Full Text] [Related]